Article
Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome.
Cardiovascular therapeutics - 1 Jan 2019
Peng Wenxing, Shi Xiujin, Xu Xiaoyu, Lin Yang
Abstract excerpt
OBJECTIVE: The objective of this study is to explore the relationships of the effects of CYP2C19 and PON1 Q192R polymorphism on the activity of clopidogrel and the risk of high platelet responsiveness (HPR) by thrombelastography in patients with acute coronary syndrome (ACS). METHODS: 459 ACS patients with aspirin and clopidogrel were enrolled in this observational case control study from July 13, 2015, to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
